Global Clinical Trial Supplies Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Clinical Trial Supplies market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Clinical Trial Supplies market."
Therapeutic areas, included in the clinical trial supplies market are oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global clinical trial supplies market in 2017. Increase in cancer incidences and government funding for cancer research are factors driving the growth of this market.
Based on regions, the global clinical trial supplies market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising prevalence of chronic diseases, growing number of clinical trials, and the increasing number of life sciences research activities in North America.

The global Clinical Trial Supplies market is valued at 950 million US$ in 2018 is expected to reach 1610 million US$ by the end of 2025, growing at a CAGR of 6.9% during 2019-2025.
This report focuses on Clinical Trial Supplies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Clinical Trial Supplies market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    ALMAC Group Ltd
    Catalent Pharma Solutions, Inc.
    Parexel International
    Thermo Fisher Scientific, Inc.
    PCI Services
    Patheon, Inc.
    Sharp Packaging Services
    Biocair
    Movianto
    Klifo A/S.

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Logistics & Distribution
    Manufacturing
    Packaging and Labeling

Segment by Application
    CNS & Mental Disorders
    Cardiovascular
    Oncology